SEC Form 4 · accession 0001213900-18-005282
NEXEON MEDSYSTEMS INC · NXNN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel P. Powell
Officer — V.P., Sales and Marketing
Period of report
Jan 31, 2018
Accepted (ET)
May 1, 2018 · 1:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001416172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF1 | Jan 31, 2018 | A | 8,160 | $0.625 | A | 8,160 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPTIONSF2 | $0.76 | Feb 28, 2018 | A | 11,000 | A | Feb 28, 2018 | Feb 28, 2021 | COMMON STOCK | 11,000 | 11,000 | D |
Explanation of responses
- F1On January August 21, 2018, the Reporting Person acquired 8,160 shares of the Company's restricted common stock as compensation for marketing services provided by the Reporting Person as a consultant prior to the Reporting Person's employment with the Company. These shares were valued at $5,100 ($0.625 per share).
- F2On February 28, 2018, and pursuant to the Company's 2016 Ominbus Incentive Plan, the Company granted to the Reporting Person an option (the "Option") to purchase 11,000 shares of the Company's restricted common stock, at a price of $0.76 per share, as compensation for service as Vice President, Sales and Marketing of the Company. The term of the Option shall be for a period of three (3) years from the date of issue. The fair value of the Option was determined to be $2,481 using the Black-Sholes Option Pricing Model. The Option was immediately exercisable at date of issue.